Harness flexible reporting to measure and plan
PharmacyElite biopharma reporting and insights support manufacturers by helping you track key metrics for newly launched journeys or understand how your existing hub program is being used. From biopharma start-ups to well-established brands, stakeholders at both the executive level and case level have access to valuable insights that can be used to shape operational improvements or drive brand enhancements.
Biopharma reporting dashboards with the details you demand
As part of our biopharma reporting and insights program, we tailor our reporting dashboards to reflect the metrics that matter most to you, whether you’re the CEO of an emerging biopharma company or a product life cycle manager representing a global manufacturer. Powered by PharmacyElite’s robust technology platform, our hub reporting and insights help biopharma partners connect the dots across complex specialty journeys to reveal:
- Overall program utilization
- Utilization by service type (e.g. Quick Start)
- Utilization by therapy type (e.g. oncology)
- Enrollment trends
- Case bottlenecks/barriers to access
- Time to therapy
- Patient prescription status and case progress
- Prescriber reimbursement support needs
High-level insights informed by industry benchmarks
Brand leaders not only have access to brand-specific journeys and trends within their own patient hub — they also have compliant access to real-world performance insights across other oncology, rare disease and cell & gene therapy hub programs. These insights can play a pivotal role in shaping program refinements and influencing future strategy changes.
Scalable for your growth
Our flexible dashboards and reporting capabilities are designed to grow with your brand as new indications or patient populations are added.
Real-world metrics to guide field reimbursement teams
For biopharma partners with field reimbursement teams, it’s essential to understand when patients are experiencing challenges to access or adherence so that they can work with the provider to resolve them. Our detailed reporting capabilities can be a powerful way to inform program performance and help move cases forward.
Flexible ramp-up periods to accommodate short launches
The fast-moving world of biopharma manufacturing frequently comes with aggressive go-to-market timelines — and PharmacyElite hub reporting and insights can accommodate short launches. Our purpose-built hub services allow for flexibility when the planning cycle demands it, putting operational needs and patient protocols ahead of reporting capabilities, which can be built out later in the engagement.
Robust reporting from the start for partners that prefer it
For biopharma brands that prioritize in-depth data reporting over the full patient journey, PharmacyElite works closely with your team in the months leading up to the launch to ensure visibility from the very beginning. This gives manufacturers a comprehensive view of the entire process, along with the ability to drill down to individual patient cases, milestones and potential bottlenecks.
Questions about hub program design or support models?
Designed for complex patient journeys
Purpose-built hub programs supporting oncology, rare disease and cell & gene therapy.
Technology-enabled hub support
Technology-enabled support designed to integrate hub services.
Supporting patient continuity
Hub-based support designed to help address barriers to care.